| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | DURHAM | NC | 27709-0152 | DURHAM | USA | R43AG072985 | Tau mislocalization assay to screen AD therapeutics using compartmentalized chips | 000 | 2 | NIH | 8/25/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | DURHAM | NC | 27709-0152 | DURHAM | USA | R43AG072985 | Tau mislocalization assay to screen AD therapeutics using compartmentalized chips | 000 | 2 | NIH | 12/8/2023 | $0 |
| | 2024 | 2020 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | DURHAM | NC | 27709-0152 | DURHAM | USA | R21NS109750 | The influence of axonal ER on retrograde synapse loss following axon damage | 000 | 1 | NIH | 1/5/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $266,581 ) |
| | 2023 | 2023 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R43AG072985 | Tau mislocalization assay to screen AD therapeutics using compartmentalized chips | 001 | 2 | NIH | 3/14/2023 | $266,581 |
| | 2023 | 2022 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R43AG072985 | Tau mislocalization assay to screen AD therapeutics using compartmentalized chips | 000 | 1 | NIH | 2/24/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $359,681 ) |
| | 2022 | 2022 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R43AG072985 | Tau mislocalization assay to screen AD therapeutics using compartmentalized chips | 000 | 1 | NIH | 1/31/2022 | $268,419 |
| | 2022 | 2022 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R43AG072985 | Tau mislocalization assay to screen AD therapeutics using compartmentalized chips | 001 | 1 | NIH | 2/3/2022 | $0 |
| | 2022 | 2020 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R21NS109750 | The influence of axonal ER on retrograde synapse loss following axon damage | 000 | 1 | NIH | 11/9/2021 | $161,659 |
| | 2022 | 2020 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R21NS109750 | The influence of axonal ER on retrograde synapse loss following axon damage | 001 | 1 | NIH | 4/28/2022 | -$70,397 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R41NS108895 | A user-friendly microfluidic chip for anti-epileptogenic drug screening | 000 | 1 | NIH | 5/15/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $322,130 ) |
| | 2020 | 2020 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R21NS109750 | The influence of axonal ER on retrograde synapse loss following axon damage | 001 | 1 | NIH | 9/8/2020 | $174,815 |
| | 2020 | 2020 | XONA MICROFLUIDICS, INC. | 104 TW ALEXANDER DR BLDG 7 STE 701 | RESEARCH TRIANGLE PARK | NC | 27709-0002 | DURHAM | USA | R21NS109750 | The influence of axonal ER on retrograde synapse loss following axon damage | 000 | 1 | NIH | 3/23/2020 | $147,315 |
| | 2020 | 2018 | XONA MICROFLUIDICS, INC. | 76 TW ALEXANDER DR | RESEARCH TRIANGLE PARK | NC | 27709-0152 | DURHAM | USA | R42MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 5 | NIH | 4/6/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2018 | XONA MICROFLUIDICS, LLC | 43300 BUSINESS PARK DR STE 204 | TEMECULA | CA | 92590-5524 | RIVERSIDE | USA | R41NS108895 | A user-friendly microfluidic chip for anti-epileptogenic drug screening | 000 | 1 | NIH | 3/7/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $563,950 ) |
| | 2018 | 2018 | XONA MICROFLUIDICS, LLC | 27574 COMMERCE CENTER DR STE 137 | TEMECULA | CA | 92590-2535 | RIVERSIDE | USA | R42MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 5 | NIH | 3/20/2018 | $338,950 |
| | 2018 | 2018 | XONA MICROFLUIDICS, LLC | 27574 COMMERCE CENTER DR STE 137 | TEMECULA | CA | 92590-2535 | RIVERSIDE | USA | R41NS108895 | A user-friendly microfluidic chip for anti-epileptogenic drug screening | 000 | 1 | NIH | 8/16/2018 | $225,000 |
|
| Issue Date FY: 2017 ( Subtotal = $890,157 ) |
| | 2017 | 2017 | XONA MICROFLUIDICS, LLC | 27574 COMMERCE CENTER DR STE 137 | TEMECULA | CA | 92590-2535 | RIVERSIDE | USA | R42MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 4 | NIH | 3/13/2017 | $805,231 |
| | 2017 | 2017 | XONA MICROFLUIDICS, LLC | 27574 COMMERCE CENTER DR STE 137 | TEMECULA | CA | 92590-2535 | RIVERSIDE | USA | R42MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 001 | 4 | NIH | 9/26/2017 | $84,926 |
|
| Issue Date FY: 2016 ( Subtotal = $763,929 ) |
| | 2016 | 2016 | XONA MICROFLUIDICS LLC | 27574 COMMERCE CENTER DRIVE | TEMECULA | CA | 92590 | RIVERSIDE | USA | R42MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 3 | NIH | 4/5/2016 | $654,065 |
| | 2016 | 2016 | XONA MICROFLUIDICS LLC | 27574 COMMERCE CENTER DRIVE | TEMECULA | CA | 92590 | RIVERSIDE | USA | R42MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 001 | 3 | NIH | 4/22/2016 | $109,864 |
| | 2016 | 2014 | XONA MICROFLUIDICS LLC | 27574 COMMERCE CENTER DRIVE | TEMECULA | CA | 92590 | RIVERSIDE | USA | R41MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 2 | NIH | 3/18/2016 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $330,481 ) |
| | 2014 | 2014 | XONA MICROFLUIDICS LLC | 27574 COMMERCE CENTER DRIVE | TEMECULA | CA | 92590 | RIVERSIDE | USA | R41MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 2 | NIH | 4/25/2014 | $330,481 |
|
| Issue Date FY: 2013 ( Subtotal = $348,284 ) |
| | 2013 | 2013 | XONA MICROFLUIDICS LLC | 27574 COMMERCE CENTER DRIVE | TEMECULA | CA | 92590 | RIVERSIDE | USA | R41MH097377 | A user-friendly scalable microfluidic platform for enhanced neuron-cell culture | 000 | 1 | NIH | 5/9/2013 | $348,284 |
|
|
